Elevated DTYMK expression level was discovered in LUAD patients belonging to subtypes C1, C2, C4, and C6, illustrating that DTYMK might be implicated in the promotion of tumor progression (Figure 3D). This evidence concerns the gene DTYMK and neoplasm.